Axogen, Inc. — Director's Dealing 2011

Dec 20, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2011-12-16

Reporting Person: Friedman Mark Louis (Vice President of RA/QA)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-12-16	Stock Option (right to buy)	$2.74	A	40000	Acquired	2018-12-16	Common Stock (40000)	Direct

Footnotes

F1: All shares pursuant to the options will be fully vested on December 16, 2015 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 16, 2012 (12 months from the option grant date) and an additional 12.5% of aggregate shares each 6 months thereafter.